Prior to administration of Tetanus Toxoid absorbed manufactured by Aventis Pasteur Inc., health-care providers should inform the parent, guardian, or adult patient of the benefits and risks of immunization.

The health-care provider should inform the parent, guardian, or adult patient about the potential for adverse reactions that have been temporally associated with the administration of Tetanus Toxoid absorbed manufactured by Aventis Pasteur Inc. or other vaccines containing similar components. The parent, guardian or adult patient should be instructed to report any serious adverse reactions to their health-care provider. Adverse events following immunization should be reported by health-care providers to the Vaccine Adverse Event Reporting System (VAERS) (see ADVERSE REACTIONS, REPORTING OF ADVERSE EVENTS).

As part of the child's or adult's permanent immunization record, the date, lot number and manufacturer of the vaccine administered MUST be recorded.^7,8,9

The health-care provider should inform the parent, guardian, or adult patient of the importance of completing the primary immunization series or receiving recommended booster doses, as appropriate.

The health-care provider should provide the Vaccine Information Statements (VISs) which are required by the National Childhood Vaccine Injury Act of 1986 to be given with each immunization.

REFERENCES

7. CDC. Vaccine Adverse Event Reporting System—United States. MMWR Morb Mortal Wkly Rep. 1990;39(41):730-733.

8. CDC. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination. MMWR Morb Mortal Wkly Rep. 1988;37(13):197-200.

9. Food and Drug Administration. New reporting requirements for vaccine adverse events. FDA Drug Bull. 1988;18(2):16-18.

Bookmark this page: